View Archive:
2010 | 2009 |
2008 |
2007 |
2006 |
2005 |
2004 |
2003 |
2002 |
2001 |
2000 |
1999 |
1998December 11, 2009
Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 Presented at the 32nd Annual San Antonio Breast Cancer Symposium
December 9, 2009
Cytokinetics and GlaxoSmithKline Agree to Terminate Collaboration and License Agreement Directed to Oncology
December 7, 2009
Cytokinetics Presents Non-Clinical Data Relating to CK-2017357 at the 5th Cachexia Conference
December 6, 2009
Cytokinetics Announces Clinical Trial Data Regarding SB-743921 Presented at the 2009 American Society of Hematology Annual Meeting and Exposition
December 3, 2009
Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 to be Presented at the 32nd Annual San Antonio Breast Cancer Symposium
November 30, 2009
Cytokinetics Announces Clinical Trial Data Regarding SB-743921 to be Presented at the 2009 American Society of Hematology Annual Meeting and Exposition
November 30, 2009
Cytokinetics to Present Non-Clinical Data Relating to CK-2017357 at the 5th Cachexia Conference
November 19, 2009
Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 Presented at the 2009 AACR-NCI-EORTC International Conference
November 17, 2009
Cytokinetics Presents Non-Clinical Data from Its Smooth Muscle Contractility Program at the 2009 Scientific Sessions of the American Heart Association
November 12, 2009
Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 to be Presented at the 2009 AACR-NCI-EORTC International Conference
November 10, 2009
Cytokinetics to Present Non-Clinical Data from Its Smooth Muscle Contractility Program at the 2009 Scientific Sessions of the American Heart Association
November 9, 2009
Cytokinetics Announces Advancement of CK-2017357 in Phase I Clinical Trials
November 6, 2009
Cytokinetics Announces Addition to Board of Directors
November 3, 2009
Cytokinetics to Present at November Healthcare Conferences
October 28, 2009
Cytokinetics, Incorporated Reports Third Quarter 2009 Financial Results
October 21, 2009
Cytokinetics to Announce Third Quarter Results on October 28, 2009
September 29, 2009
Cytokinetics to Present at the Fourth Annual JMP Securities Healthcare Focus Conference
September 18, 2009
Cytokinetics Highlights Progress and Expansion of Development Programs at Today’s Research and Development Day
September 15, 2009
Cytokinetics Presents Phase IIa Clinical Trials Data on Omecamtiv Mecarbil at the 2009 Heart Failure Society of America Annual Meeting
September 11, 2009
Cytokinetics to Host a Research and Development Day on Friday, September 18th
September 9, 2009
Cytokinetics to Present at the Newsmakers in the Biotech Industry Conference
September 8, 2009
Cytokinetics to Present Phase IIa Clinical Trials Data on Omecamtiv Mecarbil at the 2009 Heart Failure Society of America Annual Meeting
August 31, 2009
Cytokinetics Presents Phase IIa Clinical Trials Data Relating to Omecamtiv Mecarbil at the European Society of Cardiology Congress 2009
August 24, 2009
Cytokinetics to Present Phase IIa Clinical Trials Data on Omecamtiv Mecarbil at the European Society of Cardiology Congress 2009
July 29, 2009
Cytokinetics, Incorporated Reports Second Quarter 2009 Financial Results
July 22, 2009
Cytokinetics to Announce Second Quarter Results on July 29, 2009
June 18, 2009
Cytokinetics Announces the Initiation of a First-Time-In-Humans, Phase I Clinical Trial of CK-2017357
June 4, 2009
Cytokinetics to Present at the Eighth Annual Needham Life Sciences Conference
June 2, 2009
Cytokinetics Presents Clinical Data Relating To Ispinesib in Patients with Metastatic Breast Cancer at the 2009 Annual Meeting of the American Society of Clinical Oncology
June 1, 2009
Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 Presented at the 2009 Annual Meeting of the American Society of Clinical Oncology
June 1, 2009
Cytokinetics Announces Presentations of Data From Phase IIa Clinical Trials of CK-1827452 at the 2009 Heart Failure Congress of the European Society of Cardiology
May 30, 2009
Cytokinetics Presents Clinical Data Relating to SB-743921 in Patients with Non-Hodgkin or Hodgkin Lymphoma at the 2009 Annual Meeting of the American Society of Clinical Oncology
May 26, 2009
Amgen Exercises Option for Exclusive License to Cytokinetics’ Cardiac Contractility Program That Includes CK-1827452
May 25, 2009
Cytokinetics to Hold a Conference Call Tuesday, May 26, 2009 at 9 AM Eastern Time to Discuss its Collaboration and Option Agreement with Amgen
May 22, 2009
Cytokinetics to Present Phase IIa Clinical Trials Data on CK-1827452 at the 2009 Heart Failure Congress of the European Society of Cardiology
May 19, 2009
Cytokinetics Announces Registered Direct Common Stock Offering of $14.0 Million
May 14, 2009
Cytokinetics Announces Clinical and Non-clinical Data Relating to SB-743921, Ispinesib and GSK-923295 to be Presented at the 2009 Annual Meeting of the American Society of Clinical Oncology
May 14, 2009
Cytokinetics to Hold Annual Meeting of Stockholders
May 12, 2009
Cytokinetics to Present at the Eighth Annual JMP Securities Conference
May 7, 2009
Cytokinetics Presents Non-clinical Data from its Smooth Muscle Contractility Program at the American Society of Hypertension 24th Annual Scientific Meeting and Exposition
May 5, 2009
Cytokinetics to Present at the Bank of America and Merrill Lynch Healthcare Conference
May 4, 2009
Cytokinetics Announces Non-clinical Data Relating to its Smooth Muscle Contractility Program to be Presented at the American Society of Hypertension 24th Annual Scientific Meeting and Exposition
April 30, 2009
Cytokinetics, Incorporated Reports First Quarter 2009 Financial Results
April 23, 2009
Cytokinetics to Announce First Quarter Results on April 30, 2009
April 22, 2009
Cytokinetics Announces Non-clinical Data Relating to GSK-923295 Presented at the 2009 American Association of Cancer Research Annual Meeting
April 20, 2009
Cytokinetics Announces Non-Clinical Data Relating to CK-2017357 Presented at the 2009 Experimental Biology Conference
April 15, 2009
Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 to be Presented at the 2009 American Association of Cancer Research Annual Meeting
April 13, 2009
Cytokinetics Announces Non-Clinical Data Relating to CK-2017357 to be Presented at the 2009 Experimental Biology Conference
March 30, 2009
Cytokinetics Announces Final Phase IIA Clinical Trial Data for CK-1827452 Presented at The 2009 Annual Scientific Sessions of The American College of Cardiology
March 23, 2009
Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 to be Presented at the 2009 Annual Scientific Sessions of The American College of Cardiology
March 4, 2009
Cytokinetics Announces Non-clinical Data Relating to Its Skeletal Muscle Contractility Program Presented at the Biophysical Society 53rd Annual Meeting
February 25, 2009
Cytokinetics Delivers Clinical Trials Data to Inform Amgen’s Option Relating to CK-1827452
February 23, 2009
Cytokinetics Announces Non-clinical Data Relating to its Skeletal Muscle Contractility Program to be Presented at the Biophysical Society 53rd Annual Meeting
February 19, 2009
Cytokinetics Announces Addition to Board of Directors
February 10, 2009
Cytokinetics, Incorporated Reports Fourth Quarter and Year End 2008 Financial Results
February 3, 2009
Cytokinetics to Announce Fourth Quarter and Year End Results on February 10, 2009
February 2, 2009
Cytokinetics to Present at BIO CEO and Investor Conference
January 12, 2009
Cytokinetics Announces Updates Relating to Muscle Biology Research and Non-clinical Development Programs
January 9, 2009
Cytokinetics to Present at the 27th Annual JPMorgan Healthcare Conference
